Issued Patents All Time
Showing 1–25 of 32 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12410133 | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof | Nancy Tsou, Nicole S. White, Jun Xu, Qun Zhang | 2025-09-09 |
| 12391672 | Solid forms comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | Antonio Christian Ferretti, Udaykumar Jain, Hon-Wah Man, Paula A. Tavares-Greco, Wenju Wu | 2025-08-19 |
| 12049446 | Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof | Daozhong Zou | 2024-07-30 |
| 11958805 | Solid forms comprising an oxime ether compound, compositions and methods of use thereof | Daozhong Zou | 2024-04-16 |
| 11701362 | Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamide | Scott Bone, Tracy Lee Gaebele, Yu Pu | 2023-07-18 |
| 11680046 | Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof | Nancy Tsou, Nicole S. White, Jun Xu, Qun Zhang | 2023-06-20 |
| 11629124 | Solid forms comprising an oxime ether compound, compositions and methods of use thereof | Daozhong Zou | 2023-04-18 |
| 11629153 | Forms and compositions of a MK2 inhibitor | Jianxin Han, Uday Jain, Ying Li, John Malona, Kevin Molter +4 more | 2023-04-18 |
| 11578056 | Solid forms comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and salts thereof, and compositions comprising and methods of using the same | Wenju Wu | 2023-02-14 |
| 11434200 | Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof | Daozhong Zou | 2022-09-06 |
| 11370777 | Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same | Gerald D. Artman, III, Antonio Christian Ferretti, Udaykumar Jain, Hon-Wah Man, Paula A. Tavares-Greco +3 more | 2022-06-28 |
| 11186556 | Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof | Daozhong Zou | 2021-11-30 |
| 11053199 | Crystalline (R)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, compositions and methods of use thereof | Nancy Tsou, Nicole S. White, Jun Xu, Qun Zhang | 2021-07-06 |
| 11013723 | Solid forms of a thiazolidinone compound, compositions and methods of use thereof | Daozhong Zou | 2021-05-25 |
| 11014897 | Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof | Daozhong Zou | 2021-05-25 |
| 10898488 | Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Scott Bone, Tracy Lee Gaebele, Yu Pu | 2021-01-26 |
| 10882867 | Forms and compositions of a MK2 inhibitor | Jianxin Han, Uday Jain, Ying Li, John Malona, Kevin Molter +4 more | 2021-01-05 |
| 10653697 | Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Scott Bone, Tracy Lee Gaebele, Yu Pu | 2020-05-19 |
| 10590089 | Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide | Nathan Boersen, Indrajit Ghosh, Daozhong Zou | 2020-03-17 |
| 10543214 | Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide | Scott Bone, Tracy Lee Gaebele, Yu Pu | 2020-01-28 |
| 10513519 | Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use | Zheng Chen, Paul F. Fernandez, Tracy Lee Gaebele, Matthew Jackson, Matthew Michael Kreilein +3 more | 2019-12-24 |
| 10202364 | Forms and compositions of an ERK inhibitor | Antonio Christian Ferretti, Ying Li, John Traverse, Jean Xu, Kelvin Hin-Yeong Yong +1 more | 2019-02-12 |
| 10131639 | Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrimidine-5-carboxamide | Nathan Boersen, Indrajit Ghosh, Daozhong Zou | 2018-11-20 |
| 10047090 | Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use | Zheng Chen, Paul F. Fernandez, Tracy Lee Gaebele, Matthew Jackson, Matthew Michael Kreilein +3 more | 2018-08-14 |
| 10005760 | Forms and compositions of an ERK inhibitor | Antonio Christian Ferretti, Ying Li, John Traverse, Jean Xu, Kelvin Hin-Yeong Yong +1 more | 2018-06-26 |